Introduction {#S1}
============

Colistin is one of the primary classes of antibiotics with activity against most gram-negative bacteria and is considered the last resort antibiotic for the treatment of infections caused by carbapenem-resistant Enterobacteriaceae. In 2015, a plasmid-encoded colistin resistance gene named *mcr-1* was described in Enterobacteriaceae isolated from humans and livestock in China ([@B21]). Since then, polymyxins have rightfully drawn renewed attention to colistin resistance, and plasmid-mediated colistin resistance by *mcr-1* has been reported worldwide in livestock, food and humans ([@B24]; [@B20]). The *mcr-1* gene confers colistin resistance by encoding a phosphoethanolamine transferase that catalyzes the addition of a phosphoethanolamine moiety to lipid A in the bacterial outer membrane (OM) ([@B12]; [@B17]), which may modify the structure of lipid A and then decrease the growth rate, cell viability, and competitive ability and shape cytoplasmic structures ([@B28]).

The OM of gram-negative bacteria plays a crucial role in protecting cells against an adverse environment and exchanging material ([@B9]). To work effectively, antibiotics must pass across the OM barricade to reach the inhibitory concentration inside the bacterial cell ([@B26]). Bacterial OMs with low permeability have been identified as robust barriers that prevent many antibiotics from reaching their intracellular targets ([@B23]). Antibiotics usually traverse the OM by one of two mechanisms: the lipid-mediated pathway responsible for macrolides and hydrophobic antibiotics, such as aminoglycosides (gentamycin, kanamycin), and general diffusion porins for hydrophilic antibiotics such as β-lactams ([@B5]; [@B23]). The lipid and protein compositions of the OM have a major impact on the susceptibility of the microorganism to antibiotics, and drug resistance involving modifications of these macromolecules is common ([@B5]). For instance, several studies showed that alternations in the hydrophobic properties of the membrane or null mutations in porins create resistance to β-lactam antibiotics ([@B22]; [@B13]). MCR-1 is a membrane-bound enzyme consisting of five hydrophobic transmembrane helixes and a soluble form located in the periplasmic space ([@B21]). A recent study reported that mutants with a high-level colistin resistance are more susceptible to most antibiotics compared with their respective parental strains ([@B28]). However, whether other antibiotic resistances could be affected by expression of *mcr-1* remain unclear. Since *mcr-1* encodes a phosphoethanolamine transferase that modifies the structure of LPS of the OM, it raises the possibility that MCR-1 may affect the susceptibility of bacteria to hydrophobic antibiotics by changing the membrane permeability. Therefore, we analyzed the impact of *mcr-1* expression on the membrane permeability of *E*. *coli* by constructing an *mcr-1* deletion mutant strain and by constructing a vector to overexpress *mcr-1*.

Materials and Methods {#S2}
=====================

Bacterial Strains, Plasmids, and Growth Conditions {#S2.SS1}
--------------------------------------------------

The bacterial strains and plasmids used in this study are listed in [Table 1](#T1){ref-type="table"}, and the sequences of primers used in this study are listed in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. The *E*. *coli* strains were grown in Luria--Bertani (LB) broth or on LB agar plates (with 10 g NaCl per liter) at 37°C, except for *E*. *coli* carrying pKD46 or pCP20, which were grown at 30°C. Antibiotics and other chemicals were used at the following final concentrations: chloramphenicol, 30 μg/ml; polymyxin B, 2 μg/ml; ampicillin, 100 μg/ml; isopropyl-β-d-thiogalactopyranoside (IPTG), 0.5 mM; and arabinose, 1 mM. A total of 1 mM L-arabinose or 0.5 mM IPTG (Sigma) was used to induce P*ara* or P*lac*, respectively.

###### 

Strains and plasmids used in this study.

  **Strains/Plasmids**    **Phenotypes**                                                                                        
  ----------------------- ----------------------------------------------------------------------------------------------------- ------------
  **Strains**                                                                                                                   
  *E. coli* K12 BW25113   *lacI*^q^ *rrnB*~T14~ *ΔlacZ*~WJ16~ *hsdR514 ΔaraBAD*~AH33~ *ΔrhaBAD*~LD78~                           [@B4]
  *E. coli* C600          *F-thr-1 leuB6(Am) fhuA21 cyn-101 lacY1 glnX44(AS) λ*^--^ *e14-rfbC1 glpR200(glp^c^) thiE1*           [@B3]
  Wild type               *E*. *coli* BW25113/pHNSHP45                                                                          This study
  Δ*mcr-1*:*cat*          *E*. *coli* BW25113/pHNSHP45Δ*mcr-1* Cm^R^                                                            This study
  Δ*mcr-1*                *E*. *coli* BW25113/pHNSHP45Δ*mcr-1*ΔCm^R^                                                            This study
  **Plasmids**                                                                                                                  
  pHNSHP45                *mcr-1*, GenBank accession no. [KP347127](KP347127)                                                   [@B21]
  pKD46                   Amp^R^, λ Red recombinase expression                                                                  [@B10]
  pKD3                    FRT-flanked *cat* gene (Cm^R^) in *oriR*γ replicon requiring the *pir* gene product                   [@B10]
  pCP20                   Amp^R^ and Cm^R^; temperature-sensitive replication, thermal induction of FLP recombinase synthesis   [@B4]
  pCA24N                  Cm^R^; *lacI*^q^, IPTG inducible expression vector in *E. coli*                                       [@B19]
  pCA24N-*mcr-1*          Cm^R^; *lacI*^q^, P~T5--lac~:*mcr-1*                                                                  This study
  pCA24N-*mcr-1*-*gfp*    Cm^R^; *lacI*^q^, P~T5--lac~:*mcr-1-gfp*                                                              This study

Construction of the Deletion Mutant {#S2.SS2}
-----------------------------------

The coding region of the *mcr-1* gene was deleted from *E. coli* K12 BW25113 carrying plasmid pHNSHP45 ([@B21]) following a one-step inactivation method ([@B10]). The primers used in this study are shown in [Supplementary Table S1](#SM1){ref-type="supplementary-material"}. PCR products containing chloramphenicol resistance cassettes flanked by 39 bp of homology to the 5′ and 3′ termini of *mcr-1* were electroporated into competent cells of parent strains carrying pKD46. To construct the *mcr-1* deletion mutant, PCR products that included 37-nt homology extensions and 20-nt priming sequences for the chloramphenicol resistance gene *cat*, bordered by FLP recombination target (FRT) sites, were amplified from plasmid pKD3 (*cat*) using primers pKD46-mcrF/pKD46-mcrR. Removal of the *mcr-1* gene from pHNSHP45 in *E. coli* was verified by PCR and DNA sequencing using the primer pair MCR-LF/MCR-LR. The FRT-flanked chloramphenicol cassette was removed after transformation with pCP20 as described previously ([@B10]). pCP20 is a plasmid that carries ampicillin and chloramphenicol resistance genes and exhibits temperature-sensitive replication and thermal induction of FLP synthesis ([@B7]). CmR mutants were transformed with pCP20, and ampicillin-resistant transformants were selected at 30°C, propagated non-selectively at 42°C and then tested for loss of all antibiotic resistances.

Plasmid Constructs {#S2.SS3}
------------------

The pCA24N vector was used to express target genes in *E. coli*. The coding region of *mcr-1* was PCR-amplified from genomic DNA of *E. coli* carrying pHNSHP45 using the primer pair pCA24N-mcrF/pCA24N-mcrR. PCR products were digested with *Sal*I and *Xba*I and inserted into the corresponding sites of pCA24N. The correct constructs were verified by PCR with primer pair pCA24N-F/pCA24N-R and DNA sequencing. The same procedures were performed to fuse *gfp* before the stop codon of the *mcr-1* gene, as well as for the construction of the plasmid pCA24N-*mcr-1-gfp*. To generate pCA24N-*mcr-1-gfp*, the coding region of *mcr-1* without its stop codon was amplified with primers Mcr-1F(salI) and Mcr-1R(xbaI), and the coding region of *gfp* was amplified using pCA24N-*gfp* ([@B16]) as the template with primers Gfp-F(xbaI) and Gfp-R(*Eco*RI). The *mcr-1* fragment was digested with *Sal*I and *Xba*I, the *gfp* fragment was digested *Xba*I and RcoRI, and inserted into the corresponding sites of pCA24N. pCA24N-based expression vectors were transferred into the *E. coli* BW25113 host.

Antibiotics Susceptibility Testing {#S2.SS4}
----------------------------------

The antibiotics tested include ampicillin, polymyxin B (PB), ceftazidime, ciprofloxacin, gentamycin (GEN), kanamycin, chloramphenicol, tetracycline, rifampicin, nalidixic acid, and spectinomycin. The antibiotic resistance level was described by the minimum inhibitory concentrations (MICs) determined using a custom-made 96-well MIC panel ([@B11]). The results were interpreted according to the criteria of the Clinical and Laboratory Standards Institute (CLSI) ([@B8]).

Microscopy Exam {#S2.SS5}
---------------

To evaluate cell membrane integrity, the membrane-specific red-fluorescent dye FM4-64 (Thermo Fisher Scientific, Rockford, IL, United States) was used. Overnight cultures were diluted in 50 ml of fresh medium and cultured to an OD~600\ nm~ of 0.5, and cells were harvested by centrifugation (6000 × *g*, 2 min), washed and resuspended in phosphate buffered saline (PBS). Cells were then treated with 0.85% NaCl or 7.0% NaCl for 30 min followed by staining with 4 μg/ml FM 4-64 for 15 min in the dark at ambient temperature. Bacterial cells were imaged using a Zeiss Axiovert fluorescence microscope (Carl Zeiss Inc., Thornwood, NY, United States).

Protein Localization {#S2.SS6}
--------------------

For localization of MCR-1 by GFP fusion, overnight cultures of BW25113 carrying pCA24N-*mcr-1*-*gfp* were inoculated into LB broth supplemented with chloramphenicol (30 μg/ml) to an OD~600\ nm~ of 0.1 and 0.5 mM IPTG was added to induce MCR-1-GFP expression for 2 h before imaging. Cells were washed with PBS and imaged with fluorescence microscopy (Zeiss Axiophot) using an oil immersion objective (100×).

Results and Discussion {#S3}
======================

The Expression of *mcr-1* Decreases Resistance to Hydrophobic Antibiotics {#S3.SS1}
-------------------------------------------------------------------------

The plasmid pHNSHP45 was extracted from *E*. *coli* K12 C600/pHNSHP45 using the EZNA^®^ plasmid mini kit I (Omega) and then electroporated into the *E*. *coli* K12 BW25113 host, which is susceptible to polymyxin B (MIC = 0.5 μg/mL). Positive clones were selected with 2 μg/mL polymyxin B and confirmed by PCR with the primer pair CLR5-F/R ([Supplementary Table S1](#SM1){ref-type="supplementary-material"}). To explore the impact of *mcr-1*, we deleted the *mcr*-1 gene with a one-step inactivated method using a λ-red recombinase expression plasmid pKD46 as described by [@B10]. The replacement of the *mcr-1* gene with the *cat* cassette amplified from pKD3 (strain BW25113/pHNSHP45 Δ*mcr-1*:*cat*) and the elimination of the FRT-flanked *cat* cassette by using the FLP recombinase expression plasmid pCP20 to obtain strain BW25113/pHNSHP45 Δ*mcr-1* were confirmed by PCR and DNA sequencing ([Figure 1](#F1){ref-type="fig"}). As expected, the deletion of *mcr-1* resulted in decreased resistance to polymyxin B (MIC = 0.5 μg/mL) ([Figure 1B](#F1){ref-type="fig"}). The MIC value of PB for the *mcr-1* deletion mutant was 0.5 μg/ml compared to an 8 μg/ml for the wild type ([Table 2](#T2){ref-type="table"}).

![Confirmation of the deletion of *mcr-1* from *E*. *coli* K12 BW25113/pHNSHP45. **(A)** PCR detection of *mcr-1* deletion mutants using the *mcr-1* flanking primer pair MCR-LF/LR. M, DNA marker DS5000. 1, the wild-type strain (*E*. *coli* K12 BW25113/pHNSHP45); 2, the deletion mutant Δ*mcr-1*:*cat* (*E*. *coli* K12 BW25113/pHNSHP45 Δ*mcr-1*:*cat*); 3, the deletion mutant Δ*mcr-1* (*E*. *coli* K12 BW25113/pHNSHP45 Δ*mcr-1*). **(B)** The polymyxin B (PB) susceptibility test of the wild-type strain and the Δ*mcr-1* strain.](fmicb-10-03015-g001){#F1}

###### 

Antimicrobial susceptibility of *E*. *coli* BW25113, the wild-type strain and the *mcr-1* deletion mutant.

  **Antibiotics**   **MIC (μg/mL)**           
  ----------------- ----------------- ------- -------
  Polymyxin B       0.5               8       0.5
  Gentamicin        16                8       16
  Kanamycin         8                 4       8
  Rifampicin        16                8       16
  Ampicillin        4                 4       4
  Ciprofloxacin     0.125             0.125   0.125
  Ceftazidime       0.5               0.5     0.5
  Chloramphenicol   8                 8       8
  Tetracycline      4                 4       4
  Nalidixic acid    4                 4       4
  Spectinomycin     32                32      32

MIC values (μg/mL) of 11 antibiotics are listed. Three independent cultures of each strain were tested.

The asymmetric lipopolysaccharide (LPS)-phospholipid bilayer of the OM provides a formidable permeability barrier for both hydrophilic and hydrophobic antibiotics ([@B23]; [@B29]). Previous studies have found that small hydrophilic drugs use the pore-forming porins to cross the OM, while hydrophobic drugs diffuse across the LPS-phospholipid bilayer ([@B25]; [@B23]). To explore whether MCR-1 expression demonstrates differences in different families of antibiotics, we performed MIC tests of the Δ*mcr-1* and wild-type strains using a 96-well MIC panel test assay that contained 11 antibiotics. As expected, the Δ*mcr-1* strain showed increased resistance to gentamicin, kanamycin and rifampicin. However, no effect was found for resistance to ampicillin, nalidixic acid, spectinomycin, or ciprofloxacin ([Table 2](#T2){ref-type="table"}). Interestingly, gentamicin, kanamycin, and rifampicin are hydrophobic antibiotics, while ampicillin, nalidixic acid, spectinomycin, and ciprofloxacin are hydrophilic antibiotics. Thus, the deletion of *mcr-1* also increases resistance to hydrophilic antibiotics. *mcr-1* confers colistin resistance through the addition of cationic phosphoethanolamine (pEtN) to phosphate groups on the lipid A component of LPS, which reduces the net anionic charge of the cell surface ([@B18]). LPS modification in Gram-negative bacteria plays a significant role in resistance to antimicrobial factors ([@B15]). Thus, we proposed that the expression of *mcr-1* resulted in the modification of LPS and disrupt the organization of the LPS-phospholipid bilayer, change its permeability, and therefore decrease the resistance to hydrophobic antibiotics, but the hydrophilic antibiotics traverse the OM through porin channels.

The Expression of *mcr-1* Decreases Survival During High Salt Stress {#S3.SS2}
--------------------------------------------------------------------

Acquired antibiotic resistance by horizontal gene transfer tends to be related to a fitness cost for bacterial hosts ([@B2]; [@B1]; [@B27]). The osmotic stresses of *E*. *coli* strains with and without *mcr-1* were tested. The growth of the wild type strain was severely hindered in the presence of 7.0% NaCl in LB broth (total NaCl concentration was 7.0%) when compared with the Δ*mcr-1* strain, while no growth defect was observed for the two strains in regular LB broth containing 1.0% NaCl ([Figure 2A](#F2){ref-type="fig"}). In addition, the growth of *E*. *coli* with or without *mcr-1* in LB broth with different NaCl concentration was tested and the cell density was measured by optical density at 600 nm. The results showed that the cell density of the *E*. *coli* was decreased with the increase of NaCl concentration, and *E*. *coli* without *mcr-1* was able to tolerance to higher NaCl concentration than *E*. *coli* with *mcr-1* ([Supplementary Table S2](#SM1){ref-type="supplementary-material"}). Furthermore, we examined cell integrity using the red membrane dye FM 4-64 (Life Technologies, United States), which specifically stains the cell membrane. Exponentially growing cells (OD~600\ nm~∼ 0.5) were collected, washed and incubated with 0.85% NaCl or 7.0% NaCl for 30 min. Cells were then collected and imaged by fluorescence microscopy (Zeiss Axiophot) using an oil immersion objective (100×). The cell membranes appeared intact in the presence of low concentrations of NaCl, while membrane integrity of wild type strain was only severely reduced in the presence of 7% NaCl (The membrane defects of wild type strain was about 79.2% compared with Δ*mcr-1* strain is 19.4%) ([Figure 2B](#F2){ref-type="fig"}). Consistent with the above results, the Δ*mcr-1* strain demonstrated 10-fold higher viability than the wild-type cells in the presence of 7% NaCl ([Figure 2C](#F2){ref-type="fig"}). Taken together, these results showed that the expression of the *mcr-1* gene decreases tolerance to high salt stress. We proposed that the mechanism of the expression of the *mcr-1* gene decreases cell fitness under high salt conditions may be due to expression of the *mcr-1* gene affects the membrane permeability.

![The effect of *mcr-1* expression on the osmotic tolerance of *E*. *coli*. **(A)** Growth of the two strains in LB broth containing 1% NaCl or LB broth containing 7% NaCl. **(B)** Phase-contrast microscopy and fluorescence images of Δ*mcr-1* and wild-type cells. Exponentially growing cells (OD~600\ nm~∼ 0.5) were taken after 30 min of incubation with LB broth containing 0.85% NaCl or 7.0% NaCl. **(C)** Cell viability of exponentially growing cells (OD~600\ nm~∼0.5) after 30 min of incubation with LB broth containing 0.85% NaCl or 7.0% NaCl. Experiments were conducted with three independent cultures, and only representative images are shown in panels **(B,C)**. **(D)** Colony morphology of *E. coli* with or without *mcr-1* on LB agar plates.](fmicb-10-03015-g002){#F2}

The Expression of *mcr-1* Affects the Growth and Cell Morphology of *E*. *coli* {#S3.SS3}
-------------------------------------------------------------------------------

After prolonged incubation on LB agar plates for 24 h, the edge of the colonies formed by the Δ*mcr-1* strain appeared more wrinkle compared with the wild-type strain ([Figure 2D](#F2){ref-type="fig"}). Furthermore, the *mcr-1* coding region from pHNSHP45 was cloned into plasmid pCA24N to construct pCA24N-*mcr-1*. To further check the cell morphology of *E*. *coli*, the complementation experiments were carried out. As expected, the edge of the colonies formed by the Δ*mcr-1*/pCA24N strain appeared more wrinkle compared with the Δ*mcr-1*/pCA24N-*mcr-1* ([Figure 2D](#F2){ref-type="fig"}). Scanning electron microscopy (SEM) was then employed to study the cell morphology of *E*. *coli* K-12 BW25113/pCA24N-*mcr-1* with the addition of 0.5 mM IPTG. As shown in [Figure 3A](#F3){ref-type="fig"}, cells overexpressing *mcr-1* via pCA24N-*mcr-1* had rougher cell envelopes than the cells carrying empty pCA24N. In addition, overexpression of *mcr-1* significantly reduced the cell growth rate ([Figure 3B](#F3){ref-type="fig"}), which is consistent with a recent report indicating that increased expression of *mcr-1* results in decreased growth rate and cell viability ([@B28]). To further check the localization of MCR-1 in *E*. *coli*, the green fluorescence protein gene *gfp* was fused to the C-terminus of the *mcr-1* gene to express the fused protein MCR-1-GFP. As expected, MCR-1-GFP was located around the cellular membrane ([Figure 3C](#F3){ref-type="fig"}), which further confirmed that MCR-1 is a membrane protein. As a control, the green fluorescence protein GFP was produced using pCA24N-*gfp* and the protein GFP was localized to the cytoplasm ([Supplementary Figure S1](#SM1){ref-type="supplementary-material"}). To further determine if the MCR-1-GFP fusion protein confers polymyxin resistance, we performed MIC tests of the BW25113/pCA24N and BW25113/pCA24N-*mcr-1*-*gfp* strains using a 96-well MIC panel test assay. The MIC value of PB for the BW25113/pCA24N-*mcr-1*-*gfp* was 8.0 μg/ml, but BW25113/pCA24N was 0.5 μg/ml, suggesting that GFP fused to the MCR-1 does not affect the polymyxin resistance of MCR-1. Thus, MCR-1 is localized at the membrane, and the expression of *mcr-1* affects cellular morphology and colony morphology.

![The effect of *mcr-1* expression on the morphology of *E*. *coli*. **(A)** SEM of *E*. *coli* K-12 BW25113 carrying empty plasmid or pCA24N-*mcr-1*. **(B)** Cell viability of *E*. *coli* K-12 BW25113 carrying empty plasmid or pCA24N-*mcr-1*. When the cell density reached to OD~600\ nm~ of 0.5, IPTG was added to the final concentration of 0.5 mM and the growth curve was established by monitoring cell density (CFU/mL) every 1 h via plate count method. Three independent cultures of each strain were tested. **(C)** Localization of the fused protein MCR-1-GFP. BW25113 carrying pCA24N-*mcr-1-gfp* was induced by 0.5 mM IPTG for 2 h. Cells were examined by phase contrast microscopy (upper panel) and fluorescence microscopy (middle panel). At least two independent cultures were tested and only representative images are shown in panels **(A,C)**.](fmicb-10-03015-g003){#F3}

Conclusion {#S4}
==========

In this study, we demonstrated that MCR-1 is a membrane protein that localizes to the cellular membrane. Furthermore, MCR-1 increases the loss of the cell membrane integrity and decreases the MICs of gentamicin, kanamycin and rifampicin. Evolving colistin resistance by acquiring *mcr-1* therefore challenges bacterial populations with an evolutionary trade-off: input of *mcr-1* protects the host against colistin but changes the membrane permeability and reduces resistance to hydrophobic antibiotics. This trade-off may further explain the balance between *mcr-1* expression and bacterial survival. Several studies have documented a link between antibiotic use and the development of antibiotic resistance ([@B14]; [@B6]). Our results provide a further possibility of *mcr-1* gene transfer, which was affected not only by colistin use but also by environmental cues, such as osmotic pressure conditions.
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